









市場
/
株式
/
nasdaq-tech
/

Bio-Techne Corp

TECH

65.850USD

+2.360+3.72%

終値 11/25, 16:00（ET）15分遅れの株価

10.26B時価総額

131.57直近12ヶ月PER



Bio-Techne Corp

65.850

+2.360+3.72%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Bio-Techne Corp 企業名

Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.

Bio-Techne Corpの企業情報



企業コードTECH

会社名Bio-Techne Corp

上場日Feb 09, 1989

最高経営責任者「CEO」Mr. Kim Kelderman

従業員数3100

証券種類Ordinary Share

決算期末Feb 09

本社所在地614 Mckinley Pl N E

都市MINNEAPOLIS

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号55413

電話番号16123792956

ウェブサイトhttps://www.bio-techne.com/

企業コードTECH

上場日Feb 09, 1989

最高経営責任者「CEO」Mr. Kim Kelderman

Bio-Techne Corpの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. John L. Higgins

Independent Director

66.88K

+2.51%

Mr. Kim Kelderman

President, Chief Executive Officer, Director

48.66K

-4.52%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

46.50K

+3.66%

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

15.41K

+11.91%

Dr. Rupert J. Vessey, Ph.D.

Independent Director

10.99K

+17.55%

Ms. Julie L. Bushman

Independent Director

8.78K

+22.99%

Dr. Matthew F. Mcmanus

President - Diagnostics and Spatial Biology

4.74K

+169.49%

Mr. Shane Bohnen

Senior Vice President, General Counsel, Corporate Secretary

4.38K

Dr. Judith V. Klimovsky, M.D.

Independent Director

3.78K

+76.56%

Mr. James T. (Jim) Hippel

Chief Financial Officer, Executive Vice President - Finance

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. John L. Higgins

Independent Director

66.88K

+2.51%

Mr. Kim Kelderman

President, Chief Executive Officer, Director

48.66K

-4.52%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

46.50K

+3.66%

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

15.41K

+11.91%

Dr. Rupert J. Vessey, Ph.D.

Independent Director

10.99K

+17.55%

Ms. Julie L. Bushman

Independent Director

8.78K

+22.99%

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Consumables

972.29M

79.72%

Instruments

112.09M

9.19%

Service

111.57M

9.15%

Royalty

23.69M

1.94%

地域別USD

会社名

収益

比率

United States

683.23M

56.02%

EMEA, excluding U.K

266.31M

21.83%

Greater China

100.46M

8.24%

APAC, excluding Greater China

77.26M

6.33%

United Kingdom

54.83M

4.50%

Rest of World

37.55M

3.08%

事業別

地域別

事業別USD

会社名

収益

比率

Consumables

972.29M

79.72%

Instruments

112.09M

9.19%

Service

111.57M

9.15%

Royalty

23.69M

1.94%

株主

更新時刻: Sun, Nov 16

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

11.48%

BlackRock Institutional Trust Company, N.A.

5.64%

State Street Investment Management (US)

3.69%

Wellington Management Company, LLP

3.28%

Atlanta Capital Management Company, L.L.C.

3.17%

他の

72.73%

株主統計

比率

The Vanguard Group, Inc.

11.48%

BlackRock Institutional Trust Company, N.A.

5.64%

State Street Investment Management (US)

3.69%

Wellington Management Company, LLP

3.28%

Atlanta Capital Management Company, L.L.C.

3.17%

他の

72.73%

種類

株主統計

比率

Investment Advisor

57.86%

Investment Advisor/Hedge Fund

34.00%

Hedge Fund

8.05%

Bank and Trust

2.18%

Research Firm

1.96%

Pension Fund

1.33%

Sovereign Wealth Fund

1.24%

Individual Investor

0.28%

Insurance Company

0.24%

機関投資家保有株



更新時刻: Wed, Oct 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q3

1198

161.18M

103.53%

-7.34M

2025Q2

1209

165.25M

105.41%

-730.33K

2025Q1

1245

168.10M

107.22%

+1.54M

2024Q4

1233

162.21M

102.61%

-6.39M

2024Q3

1205

159.40M

100.49%

-10.21M

2024Q2

1207

160.52M

101.86%

-12.24M

2024Q1

1216

162.56M

103.40%

-7.57M

2023Q4

1229

159.70M

100.98%

-3.97M

2023Q3

1217

156.41M

98.84%

-7.93M

2023Q2

1213

155.36M

98.68%

-4.04M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

18.40M

11.82%

-60.83K

-0.33%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

8.79M

5.65%

-512.26K

-5.50%

Jun 30, 2025

State Street Investment Management (US)

5.86M

3.76%

-671.30K

-10.28%

Jun 30, 2025

Atlanta Capital Management Company, L.L.C.

4.29M

2.76%

+573.23K

+15.41%

Jun 30, 2025

Geode Capital Management, L.L.C.

4.06M

2.61%

-30.89K

-0.75%

Jun 30, 2025

Invesco Capital Management LLC

3.24M

2.08%

+274.96K

+9.28%

Jun 30, 2025

Neuberger Berman, LLC

2.50M

1.61%

-526.06K

-17.38%

Jun 30, 2025

T. Rowe Price Associates, Inc.

8.62M

5.53%

-2.53M

-22.68%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 250.90M 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Feb 05, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025

Feb 17, 2025

Feb 28, 2025

Feb 14, 2025

Oct 30, 2024

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024

Nov 11, 2024

Nov 22, 2024

Nov 08, 2024

Aug 07, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024

Aug 19, 2024

Aug 30, 2024

Aug 19, 2024

May 01, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024

May 13, 2024

May 24, 2024

May 10, 2024

Feb 01, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024

Feb 12, 2024

Feb 26, 2024

Feb 09, 2024

Oct 31, 2023

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 24, 2023 going ex on Nov 09, 2023

Nov 10, 2023

Nov 24, 2023

Nov 09, 2023

Aug 08, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Sep 01, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Sep 01, 2023

Aug 17, 2023

May 03, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 26, 2023 going ex on May 12, 2023

May 15, 2023

May 26, 2023

May 12, 2023

Feb 02, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 27, 2023 going ex on Feb 10, 2023

Feb 13, 2023

Feb 27, 2023

Feb 10, 2023

Nov 01, 2022

TECH.NB Final Cash Dividend of gross USD 0.32 paid on Nov 28, 2022 going ex on Nov 10, 2022

Nov 14, 2022

Nov 28, 2022

Nov 10, 2022

詳細を見る

株式分割



日付

種類

比率

Nov 01, 2022

Split

1→4

日付

種類

比率

Nov 01, 2022

Split

1→4

よくある質問

Bio-Techne Corpの上位5名の株主は誰ですか？



Bio-Techne Corpの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は18.40M株を保有しており、これは全体の11.82%に相当します。
BlackRock Institutional Trust Company, N.A.は8.79M株を保有しており、これは全体の5.65%に相当します。
State Street Investment Management (US)は5.86M株を保有しており、これは全体の3.76%に相当します。
Atlanta Capital Management Company, L.L.C.は4.29M株を保有しており、これは全体の2.76%に相当します。
Geode Capital Management, L.L.C.は4.06M株を保有しており、これは全体の2.61%に相当します。